Lu Daopei Hospital International Lymphoma and Myeloma Center have the most professional medical team, the most advanced inspection equipment and treatment technology, provide the most personalized service for the patients. Mainly include:
1. Mature examination method, rich experience in the examination, professional interpretation of examination results.
2. Accurate clinical diagnosis, timely disease evaluation, and stratified treatment according to prognosis.
3. Flexible treatment strategy, advanced medical advice, and complete drug treatment.
4. Support from top experts, many international consultants, and strong cooperation with many hospitals.
Chemotherapy uses drugs to destroy or damage cancer cells so that they cannot reproduce. It is given either as a single drug or as a combination of drugs; combination chemotherapy can significantly increase the amount of cancer cells that are destroyed.
Radiotherapy is another common treatment option. Radiotherapy uses high-energy beams to kill cancer cells, relieve pain and pressure, reduce symptoms and improve quality of life. Radiation can be an effective treatment when used alone or in combination with chemotherapy, blood and bone marrow transplantation or immunotherapy.
Blood and bone marrow transplantation is a special treatment for people with certain types of cancer or other bone marrow disorders. In a blood and bone marrow transplant, cells normally found in the bone marrow are taken, processed and given back to the patient or another person. The aim of a blood and bone marrow transplant is to give a person healthy bone marrow cells after their own unhealthy bone marrow has been removed.
Blood and bone marrow transplants have been successfully used to treat diseases since 1964 by Dr Daopei Lu.
Targeted therapies can attack cancer cells without affecting healthy tissue, unlike radiation and chemotherapy.
Newer medicines called targeted therapies can be used with chemotherapy or sometimes alone. For example, some newer medicines target proteins that are more common on cancer cells than on normal cells. These drugs have different (and often milder) side effects than standard chemotherapy drugs and help people live longer. These include Nexavar® (sorafenib), Torisel® (temsirolimus), Afinitor® (everolimus), Sutent® (sunitinib) and others.
Radiotherapy is another common treatment option. Radiotherapy uses high-energy beams to kill cancer cells, relieve pain and pressure, reduce symptoms and improve quality of life. Radiotherapy can be an effective treatment when used alone or in combination with chemotherapy, blood or bone marrow transplantation, or immunotherapy.
A monoclonal antibody is a genetically engineered substance that binds to a specific protein antigen on the surface of cancer cells to help the body's general immune response. The monoclonal antibody is a kind of 'smart bomb' that reacts with cancer cells in a way that triggers the body to fight cancer more effectively.
Monoclonal antibodies include Rituximab and so on.
Immunotherapy is a type of biological therapy that uses the body's own immune system to fight disease. The cells, antibodies and organs of the immune system work to protect and defend the body. The immune system may also be able to tell the difference between healthy cells and cancer cells in the body and eliminate the cancer cells.
Immunotherapies are designed to boost the immune system, either directly or indirectly, by helping it to
·Making cancer cells more recognisable to the immune system and therefore more susceptible to destruction by the immune system
·Boosting the killing power of immune system cells
·Changing the way cancer cells grow so that they behave more like healthy cells - stopping the process that turns a normal cell into a cancer cell
·Boosting the body's ability to repair or replace normal cells that have been damaged or destroyed by other forms of cancer treatment, such as chemotherapy or radiotherapy
·Prevent cancer cells from spreading to other parts of the body
In our hospital, CAR-T therapy,PD-1/PD-L1 drugs, NK therapy and CIK therapy are under clinical trial. Our hospital started CAR-T clinical trial in 2015 and finished with more than 500 cases by the end of 2018. The complete remission (CR) rate is 90%.